Determining risk factors for mortality in liver transplant patients with COVID-19

Public Deposited
Analytics

Downloadable Content

Download PDF
Request Version for Screen Reader
Creator
  • Webb, G.J.
    • Other Affiliation: Oxford University Hospitals
  • Moon, A.M.
    • Affiliation: School of Medicine, Department of Medicine, Division of Gastroenterology and Hepatology
  • Barnes, E.
    • Other Affiliation: Oxford University Hospitals
  • Barritt, A.S.
    • Affiliation: School of Medicine, Department of Medicine, Division of Gastroenterology and Hepatology
  • Marjot, T.
    • Other Affiliation: Oxford University Hospitals
Abstract
  • We read with great interest the Correspondence from Bhoori and colleagues1 describing the effect of coronavirus disease 2019 (COVID-19) on their centre's adult liver transplant population.1 Within their cohort of over 150 transplant recipients, the authors identified six patients with COVID-19, including three resulting deaths. Each of those who died was transplanted over 10 years previously and were older than 65 years, male, overweight, and had hypertension and diabetes. The authors speculated as to whether these characteristics might be major risk factors for mortality.
Date of publication
Keyword
DOI
Identifier
Resource type
  • Article
Rights statement
  • In Copyright
Journal title
  • The Lancet Gastroenterology and Hepatology
Journal volume
  • 5
Journal issue
  • 7
Page start
  • 643
Page end
  • 644
Language
  • English
ISSN
  • 2468-1253
Publisher
  • Elsevier Ltd

Relations

Parents:

This work has no parents.

In Collection:

Items

Thumbnail Title Date Uploaded Visibility Actions
file details 1-s2.0-S2468125320301254-main.pdf 2020-10-07 Public Download